Establishment Labs Holdings (ESTA) Capital Expenditures (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Capital Expenditures came in at $1.9 million in Q1 2026, up 2338.16% year-on-year from $76000.0 in Q1 2025, and up 143.86% quarter-over-quarter from -$4.2 million in Q4 2025.
Establishment Labs Holdings (ESTA) Capital Expenditures (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Capital Expenditures history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 2338.16% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 316.18% increase from a year earlier, with the FY2024 full-year figure at $2.4 million, down 84.23% from the prior year.
- Capital Expenditures rose to $1.9 million in Q1 2026 per ESTA's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $15.2 million in Q4 2023 and bottomed at -$4.2 million in Q4 2025.
- The 5-year median for Capital Expenditures is $281000.0 (2022), against an average of $1.2 million.
- Across the five-year window, Capital Expenditures jumped 7796.88% in 2023 and tumbled 1306.32% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $192000.0 in 2022, then soared by 7796.88% to $15.2 million in 2023, then slumped by 120.9% to -$3.2 million in 2024, then sank by 33.32% to -$4.2 million in 2025, then surged by 143.86% to $1.9 million in 2026.
- Per Business Quant, the three latest ESTA Capital Expenditures figures stand at $1.9 million (Q1 2026), -$4.2 million (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | -4.23 Mn |
| Dec 31, 2025 | -4.23 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 76,000.00 |
| Mar 31, 2025 | 76,000.00 |
| Dec 31, 2024 | -3.17 Mn |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 15.16 Mn |
| Dec 31, 2023 | 15.16 Mn |